SCHEMBL8034682

SCHEMBL8034682

COc1ccc(CCCn2c3c(c4cc(C)ccc42)CN(C)CC3)cc1

nearest known ligand 0.88

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 17/20 0.88
HRH1 P35367 15/20 0.88
ADRA2A P08913 3/20 0.72
HTR2A P28223 3/20 0.72
HTR2C P28335 3/20 0.72
HTR7 P34969 3/20 0.72
ADRA1A P35348 3/20 0.72
MAOA P21397 1/20 0.69
MAOB P27338 1/20 0.69
DRD2 P14416 2/20 0.67
BCHE P06276 1/20 0.61
ADRA2B P18089 1/20 0.61
ADRA2C P18825 1/20 0.61
ACHE P22303 1/20 0.61
HRH2 P25021 1/20 0.61
ADRA1D P25100 1/20 0.61
HTR1D P28221 1/20 0.61
HTR1E P28566 1/20 0.61
ADRA1B P35368 1/20 0.61
DRD3 P35462 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8038733 0.94 HTR6 (0.77) HTR6HRH1ADRA2AHTR2AHTR2C
SCHEMBL8031143 0.94 HTR6 (1.00) HTR6HRH1ADRA2AHTR2AHTR2C
SCHEMBL8025066 0.91 HTR6 (0.86) HTR6HRH1ADRA2AHTR2AHTR2C
SCHEMBL8032473 0.88 HTR6 (0.88) HTR6HRH1ADRA2AHTR2AHTR2C
SCHEMBL13142353 0.87 HTR6 (0.76) HTR6HRH1ADRA2AHTR2AHTR2C
SCHEMBL8032547 0.87 HTR6 (0.88) HTR6HRH1ADRA2AHTR2AHTR2C
SCHEMBL8034680 0.87 HRH1 (0.87) HTR6HRH1ADRA2AHTR2AHTR2C
SCHEMBL8032202 0.85 HTR6 (0.75) HTR6HRH1ADRA2AHTR2AHTR2C
SCHEMBL3715259 0.84 HTR6 (1.00) HTR6HRH1ADRA2AHTR2AHTR2C
SCHEMBL8041282 0.84 HTR6 (0.81) HTR6HRH1ADRA2AHTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110039825-A1 LIGANDS OF ALPHA-ADRENOCEPTORS, DOPAMINE, HISTAMINE, IMIDAZOLINE AND SEROTONIN RECEPTORS AND THEIR USE ALLA CHEM, LLC (US) 2011-02-17 US disclosed
US-20110039825-A1 LIGANDS OF ALPHA-ADRENOCEPTORS, DOPAMINE, HISTAMINE, IMIDAZOLINE AND SEROTONIN RECEPTORS AND THEIR USE ALLA CHEM, LLC (US) 2011-02-17 US disclosed
WO-2009082268-A2 LIGANDS OF α-ADRENOCEPTORS AND OF DOPAMINE, HISTAMINE, IMIDAZOLINE AND SEROTONIN RECEPTORS AND THE USE THEREOF ALLA CHEM, LLC (US) 2009-07-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110039825-A1 LIGANDS OF ALPHA-ADRENOCEPTORS, DOPAMINE, HISTAMINE, IMIDAZOLINE AND SEROTONIN RECEPTORS AND THEIR USE ADRB3, ADRA2C, ADRB2 HTR6 40/4885HRH1 19/4885ADRA2A 11/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.